Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut–Liver Axis in Tumorigenesis and Therapy
Genes · 30.07.2025 · 16 (8) · 920
DOI: 10.3390/genes16080920 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 30.07.2025. Verfasst von Yuanji Fu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut Necker Enfants Malades, INSERM, CNRS, Université Paris Cité, F-75015 Paris, France. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver Neoplasms, Carcinoma, Hepatocellular, Carcinogenesis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Hepatic cancers, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), are major global health concerns due to rising incidence and limited therapeutic success. While traditional risk factors include chronic liver disease and environmental exposures, recent evidence underscores the significance of genetic alterations and gut microbiota in liver cancer development and progression. This review aims to integrate emerging knowledge on the interplay between host genomic changes and gut microbial dynamics in the pathogenesis and treatment of hepatic cancers.
Methods
We conducted a comprehensive review of current literature on genetic and epigenetic drivers of HCC and CCA, focusing on commonly mutated genes such as TP53, CTNNB1, TERT, IDH1/2, and FGFR2. In parallel, we evaluated studies addressing the gut–liver axis, including the roles of dysbiosis, microbial metabolites, and immune modulation. Key clinical and preclinical findings were synthesized to explore how host–microbe interactions influence tumorigenesis and therapeutic response.
Results
HCC and CCA exhibit distinct but overlapping genomic landscapes marked by recurrent mutations and epigenetic reprogramming. Alterations in the gut microbiota contribute to hepatic inflammation, genomic instability, and immune evasion, potentially enhancing oncogenic signaling pathways. Furthermore, microbiota composition appears to affect responses to immune checkpoint inhibitors. Emerging therapeutic strategies such as probiotics, fecal microbiota transplantation, and precision oncology based on mutational profiling demonstrate potential for personalized interventions.
Conclusions
The integration of host genomics with microbial ecology provides a promising paradigm for advancing diagnostics and therapies in liver cancer. Targeting the gut–liver axis may complement genome-informed strategies to improve outcomes for patients with HCC and CCA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut Necker Enfants Malades, INSERM, CNRS, Université Paris Cité, F-75015 Paris, France.
- National Tumor Bank, Department of Pathology, National Institute of Neoplastic Diseases, Surquillo 15038, Peru.
- Faculté de Médecine du Kremlin Bicêtre, University Paris-Sud, Université Paris-Saclay, 94270 Le Kremlin-Bicêtre, France.
- Cell and Tissue Biology Group, Anatomy and Cell Biology Department, University of Cantabria-IDIVAL, 39011 Santander, Spain.
ORCID-Profile: Yuanji Fu, Jenny Bonifacio-Mundaca, Íñigo Casafont
Zitieren
APA
Fu, Y., Bonifacio-Mundaca, J., Desterke, C., Casafont, Í., & Mata-Garrido, J. (2025). Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut–Liver Axis in Tumorigenesis and Therapy. Genes, 16(8), 920. https://doi.org/10.3390/genes16080920
Vancouver
Fu Y, Bonifacio-Mundaca J, Desterke C, Casafont Í, Mata-Garrido J. Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut–Liver Axis in Tumorigenesis and Therapy. Genes. 2025;16(8):920. doi:10.3390/genes16080920
BibTeX
@article{Fu2025,
author = {Fu, Yuanji and Bonifacio-Mundaca, Jenny and Desterke, Christophe and Casafont, Íñigo and Mata-Garrido, Jorge},
title = {Genomic Alterations and Microbiota Crosstalk in Hepatic Cancers: The Gut–Liver Axis in Tumorigenesis and Therapy},
journal = {Genes},
year = {2025},
volume = {16},
number = {8},
pages = {920},
doi = {10.3390/genes16080920}
}
EUVIMED